Welcome to our dedicated page for Perimeter Medical Imaging Ai news (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on Perimeter Medical Imaging Ai stock.
Perimeter Medical Imaging AI Inc (PYNKF) delivers cutting-edge imaging solutions for cancer surgery, specializing in AI-enhanced optical coherence tomography (OCT) systems. This page provides official updates on regulatory milestones, clinical research, and technological advancements shaping surgical oncology.
Investors and medical professionals will discover timely updates about the company’s FDA-cleared S-Series OCT platform, B-Series AI integration progress, and strategic partnerships. Content includes earnings reports, trial outcomes, and educational initiatives demonstrating real-world clinical impact.
Key updates cover surgical margin visualization innovations, regulatory submissions, and peer-reviewed study results. All materials are sourced directly from company filings and verified medical publications to ensure accuracy.
Bookmark this page for consolidated access to Perimeter’s latest developments in AI-driven surgical imaging. Regularly updated to reflect new achievements in precision oncology and operational growth.
Perimeter Medical Imaging AI (OTCQX: PYNKF) closed a C$3.56 million non-brokered private placement on Dec 9, 2025, issuing 19,757,306 units at C$0.18 each.
Each unit includes one common share and one warrant exercisable at C$0.35 for 60 months. Insiders led the financing: CEO Adrian Mendes purchased 11,656,642 units and insider Schiralli purchased 1,111,111 units. The company said net proceeds will support commercialization of the S-Series, product development, working capital and the pending FDA decision on the AI-powered B-Series expected in H1 2026.
Perimeter Medical Imaging AI (OTCQX: PYNKF) announced that HCA HealthONE Rose in Colorado is the first in the state to adopt Perimeter's S-Series OCT wide-field optical coherence tomography for intraoperative tissue visualization.
The S-Series is FDA-cleared for general tissue imaging, offers cellular-level resolution optimized to 2 mm for identifying tissue microstructures, and aims to reduce repeat surgeries by providing intraoperative margin insights previously only available from pathology results that can take up to 10 days.
HCA HealthONE Rose joins Perimeter's expanding commercial footprint while the company awaits a regulatory decision on its next-generation B-Series OCT which pairs OCT with artificial intelligence.
Perimeter Medical Imaging AI (OTCQX: PYNKF) reported Q3 2025 results with continued commercial traction for the FDA-cleared S-Series and ongoing review of the B-Series PMA, which the company expects in H1 2026. Key Q3 metrics: revenue $536,000 (+157% YoY, +6% QoQ), nine-month revenue $1.6M (+88% vs 2024), operating expenses down 34% YoY and 30% QoQ, net loss $2.7M (≈42% improvement YoY), and cash $1.7M. Installed S-Series devices have imaged >3,500 patients (17% increase). The company closed a units offering raising ≈$1.6M and scheduled a conference call today at 5:00 pm ET.
Perimeter Medical Imaging AI (OTCQX:PYNKF) will report its Third Quarter 2025 financial and operating results after market close on Wednesday, November 12, 2025. Management will host a webcast and conference call the same day to discuss results and provide a corporate update.
Conference call details: Date: November 12, 2025; Time: 5:00 pm Eastern Time; Dial-in: 1-800-717-1738 (Canada/US) or 1-646-307-1865 (International). The call will be broadcast live and archived on the company website.
Perimeter Medical Imaging AI (OTCQX: PYNKF) announced participation in the American Society of Breast Surgeons' Annual Strategic Futures Forum on October 21, 2025. The invitation-only event gathers healthcare, medical, and industry leaders to discuss the future of breast surgery and the role of integrated breast care teams.
Perimeter said the two-day Forum provides an intimate setting for small-group discussions on multidisciplinary collaboration among surgeons, oncologists, radiologists, nurses, genetic counselors, advanced practice providers, and patient navigators to improve outcomes and advance care delivery.
Perimeter Medical Imaging AI (OTCQX: PYNKF / TSXV: PINK) announced that CEO Adrian Mendes will present a company update at the Planet MicroCap Showcase on Wednesday, October 22, 2025 at 12:00 p.m. ET. The presentation will cover the company’s current commercial strategy and upcoming milestones.
The event is hosted in partnership with MicroCapClub at Arcadian Loft in Toronto and includes presentations, one-on-one investor meetings, and panels. Mr. Mendes’ presentation will be available live and archived via the company website, and 1x1 investor meetings are available in person at the conference venue by registration.
Perimeter Medical Imaging AI (OTCQX: PYNKF) announced that CEO Adrian Mendes will present a business update at the Small Cap Growth Virtual Investor Conference on Thursday, October 16, 2025 at 1:00 p.m. ET. The presentation will be available live and archived on the company website.
The VIC targets a global audience of small‑cap retail and institutional investors and has introduced tens of thousands of investors to over 2,000 public companies since 2010.
Perimeter Medical Imaging AI (OTCQX:PYNKF) announced its participation in Aptitude Health/TME's Fall Summit on breast cancer care in New Orleans, September 26-27, 2025. The summit brings together approximately 50 leading breast cancer physicians for discussions on advancing care for high-risk and newly diagnosed breast cancer patients.
The company will showcase its OCT (optical coherence tomography) technology, which received FDA clearance in 2021. An AI-assisted version of the technology is currently under FDA evaluation specifically for intraoperative breast cancer imaging. The technology enables surgeons to visualize margins in the operating room, potentially marking a significant advancement in intraoperative care.
Perimeter Medical Imaging AI (OTCQX:PYNKF) announced that Dr. Amelia Tower, a leading breast surgical oncologist, will present at the 2025 Annual Clinical Assembly of the American College of Osteopathic Surgeons about wide-field optical coherence tomography (OCT) in breast conserving surgery.
Dr. Tower will showcase real-world applications of Perimeter's FDA-cleared S-Series OCT, while highlighting how the technology helps visualize margins during surgery. The presentation focuses on reducing re-excision rates in breast cancer surgery through advanced imaging. An AI-assisted version of the technology is currently under FDA evaluation specifically for intraoperative breast cancer imaging.
Perimeter Medical Imaging AI (OTCQX:PYNKF) has announced a strategic collaboration with Jennifer Douglas, a breast cancer survivor and influential patient advocate. Douglas will join the company's Industry Advisory Board (IAB) and support patient education initiatives.
Douglas, diagnosed with DCIS at 41, brings significant experience as an author and advocate, having written 'A Breast Cancer Journey: Living it One Step at a Time' and being recognized by the Dr. Susan Love Foundation. She will join existing IAB members including Diana Chan (Chair), Tom Boon, and Dr. Ted James, contributing to Perimeter's mission of improving breast cancer surgery outcomes through its OCT-based imaging platform.
FAQ
What is the current stock price of Perimeter Medical Imaging Ai (PYNKF)?
What is the market cap of Perimeter Medical Imaging Ai (PYNKF)?
